G. ALBAYRAK Et Al. , "The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol," JOURNAL OF CELLULAR BIOCHEMISTRY , vol.120, no.6, pp.10564-10571, 2019
ALBAYRAK, G. Et Al. 2019. The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol. JOURNAL OF CELLULAR BIOCHEMISTRY , vol.120, no.6 , 10564-10571.
ALBAYRAK, G., Korkmaz, F. D., Tozcu, D., & DOĞAN TURAÇLI, İ., (2019). The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol. JOURNAL OF CELLULAR BIOCHEMISTRY , vol.120, no.6, 10564-10571.
ALBAYRAK, GÜLŞAH Et Al. "The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol," JOURNAL OF CELLULAR BIOCHEMISTRY , vol.120, no.6, 10564-10571, 2019
ALBAYRAK, GÜLŞAH Et Al. "The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol." JOURNAL OF CELLULAR BIOCHEMISTRY , vol.120, no.6, pp.10564-10571, 2019
ALBAYRAK, G. Et Al. (2019) . "The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol." JOURNAL OF CELLULAR BIOCHEMISTRY , vol.120, no.6, pp.10564-10571.
@article{article, author={GÜLŞAH ALBAYRAK Et Al. }, title={The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol}, journal={JOURNAL OF CELLULAR BIOCHEMISTRY}, year=2019, pages={10564-10571} }